These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 29884970)

  • 1. GBA-Associated Parkinson's Disease and Other Synucleinopathies.
    Gan-Or Z; Liong C; Alcalay RN
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):44. PubMed ID: 29884970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
    Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.
    Thaler A; Gurevich T; Bar Shira A; Gana Weisz M; Ash E; Shiner T; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2017 Mar; 36():47-51. PubMed ID: 28012950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenting symptoms of GBA-related Parkinson's disease.
    Kresojević N; Janković M; Petrović I; Kumar KR; Dragašević N; Dobričić V; Novaković I; Svetel M; Klein C; Pekmezović T; Kostić VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):804-7. PubMed ID: 25957717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of
    Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Glucocerebrosidase activity in
    Huh YE; Chiang MSR; Locascio JJ; Liao Z; Liu G; Choudhury K; Kuras YI; Tuncali I; Videnovic A; Hunt AL; Schwarzschild MA; Hung AY; Herrington TM; Hayes MT; Hyman BT; Wills AM; Gomperts SN; Growdon JH; Sardi SP; Scherzer CR
    Neurology; 2020 Aug; 95(6):e685-e696. PubMed ID: 32540937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
    Thaler A; Bregman N; Gurevich T; Shiner T; Dror Y; Zmira O; Gan-Or Z; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2018 Oct; 55():45-49. PubMed ID: 29784561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    Jesús S; Huertas I; Bernal-Bernal I; Bonilla-Toribio M; Cáceres-Redondo MT; Vargas-González L; Gómez-Llamas M; Carrillo F; Calderón E; Carballo M; Gómez-Garre P; Mir P
    PLoS One; 2016; 11(12):e0167749. PubMed ID: 28030538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study.
    Brockmann K; Srulijes K; Pflederer S; Hauser AK; Schulte C; Maetzler W; Gasser T; Berg D
    Mov Disord; 2015 Mar; 30(3):407-11. PubMed ID: 25448271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GBA mutations in Parkinson disease: earlier death but similar neuropathological features.
    Adler CH; Beach TG; Shill HA; Caviness JN; Driver-Dunckley E; Sabbagh MN; Patel A; Sue LI; Serrano G; Jacobson SA; Davis K; Belden CM; Dugger BN; Paciga SA; Winslow AR; Hirst WD; Hentz JG
    Eur J Neurol; 2017 Nov; 24(11):1363-1368. PubMed ID: 28834018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the glucocerebrosidase gene in Parkinson's disease.
    Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
    Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
    Oeda T; Umemura A; Mori Y; Tomita S; Kohsaka M; Park K; Inoue K; Fujimura H; Hasegawa H; Sugiyama H; Sawada H
    Neurobiol Aging; 2015 Dec; 36(12):3306-3313. PubMed ID: 26422360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.